Main Street Capital Corp. (MAIN) Kapitalizatsiyaning foydaga nisbati

Main Street Capital Corp (MAIN) brendining ramzi va logotipi

Main Street Capital kompaniyasi foydani maksimallashtirish uchun aksiyalar ulushlarini egallagan holda, AQSh ning o'rta hajmdagi bizneslariga faol ravishda kreditlar beradi. GURU.Markets platformasidagi bozor kapitalizatsiyasining foyda ko'rsatkichiga nisbati aktivlarning haddan tashqari qimmat baholanganligini o'z vaqtida aniqlash imkonini beradi, bunda 11.80 ushbu maxsus parametr darajasini belgilaydi. Barqaror kredit portfeli muntazam to'lovlarni ta'minlaydi, yuzlab korxonalar bo'ylab keng diversifikatsiya esa investorlarning potentsial risklarini minimallashtiradi.

Main Street Capital Corporation (MAIN) - Narxning foydaga nisbati 04.07.2022dan 12.11.2026gacha

Main Street Capital Corp. (MAIN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:MAIN - mainstcapital.com
Main Street Capital Corporation yetakchi tovari

Main Street Capital (MAIN) ga nisbatan bozor kutuvlari ko'pincha aktiv qiymati tavakkalchilik va daromad o'rtasidagi muvozanat bilan belgilanadigan yetuk siklik platosiz real holati bilan to'qnashadi. Main Street Capital (MAIN) ning P/E grafigini tahlil qilib, investor aksiya narxining sof foydaga nisbatini ko'rishi mumkin, bu esa defensiv biznes modeli uchun to'langan premiumni va quyi-o'rta bozor portfelining barqarorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar

ARCC (arescapitalcorp.com) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Blue Owl Capital (OBDC)|FSK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Golub Capital BDC Inc GBDC|Kompaniya qiymatining sof foydaga nisbati TSLX|GSBD - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati prospectstreet.com PSEC|CSWC (Capital Southwest Corporation) - Narx-foyda koeffitsiyenti|Oaktree Specialty Lending Corp - Kompaniya qiymatining sof foydaga nisbati|TRIN (Trinity Capital BDC) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Apollo MidCap MFIC|Narxning foydaga nisbati New Mountain Finance (NMFC)|tcgbdc.com (CGBD) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|PennantPark Floating Rate Capital - Narx-foyda koeffitsiyenti|P/E multiplikatori Barings BDC Inc BBDC|Bain Capital BDC Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati SLR Corp SLRC|FDUS (Fidus Investment) - Narx-foyda koeffitsiyenti|MSIF: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti CCAP|Kapitalizatsiyaning foydaga nisbati Gladstone Investment Corp GAIN|Narxning foydaga nisbati Gladstone Capital BDC (GLAD)|Narx-foyda koeffitsiyenti CION Investment Corp. CION|P/E multiplikatori PNNT (PennantPark Investment)|P/E multiplikatori palmersquarebdc.com PSBD|Saratoga Investment Corp. - P/E multiplikatori|Biznesning o‘zini qoplash muddati Runway Growth Finance Corp RWAY|tpvg.com (TPVG) - Narxning foydaga nisbati|Narx-foyda multiplikatori WHF|Narx-foyda koeffitsiyenti SWKH|GECC: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati OFS Capital Corporation (OFS)|Biznesning o‘zini qoplash muddati phenixfc.com|Rand Capital Corp. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ICMB (Investcorp Credit)|EQS - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati LRFC (loganridgefinance.com)